IMPORTANCE OF THE ENFORCEMENT OF THE LAW AND EU DIRECTIVES CONCERNING TRANSLATION OF PHARMACEUTICALS LEAFLETS by Gentiana, Qendro et al.
European Scientific Journal    December edition vol.8, No.30    ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
39 
 
IMPORTANCE OF THE ENFORCEMENT OF THE LAW AND 
EU DIRECTIVES CONCERNING TRANSLATION OF 
PHARMACEUTICALS LEAFLETS 
 
 
 
 
Qendro Gentiana 
“Planetary“ University, Faculty of Medical Sciences, Department of Pharmacy, Tirana, 
Albania 
Malaj Ledjan 
Hoti  Ela 
University of Tirana, Faculty of Medicine, Department of Pharmacy, Tirana, Albania 
 
 
Abstract  
Purpose : Confirmation  of  health  effects  caused  by  the  not  translation  of  the  leaflet  in  
the national  official  language.  Problems  in  patients  caused  by  the  absence  of  leaflets 
translation  were  verified  for  the  antibiotics  but  also  for  the  dietary  supplements. 
Method : Population  of  various  ages,  sick  or  not,  were  asked  to  answer  a  questionnaire 
about  some  basic  problems  that  were  found  in  our  daily  work.  The  survey  
was  conducted  in  several  ways  by  asking  random  people  on  the  street,  health  
center  or  by phone  calls.  The  questionnaire  had  a  geographical  expansion  in  
several  major  cities  of our  country.  Medicaments  and  dietary  supplement  products  that  
were  provided  in  study were  all  imported  and  their  leaflets  were  examined  if  they  
were  translated  into Albanian  or  not.  The  only  data  association  we  did  was  related  
to  the  same  active substance  that  had  different  dosage  forms  of  the  same  
pharmaceutical  manufacturer. This  association  has  been  done  for  ease  of  study  and  to  
have  more  precise conclusions. 
Result : After  statistical processing of results we found out that by 1500 respondents, 
60% of them did not understand the explanations for their medicines because they were in a 
foreign language, 25% were obliged to seek the assistance of relatives or friends, 10% of 
people translate paper, 5 % were not interested in trusting the doctor or the pharmacist, 
44% have had at least once a concern from incorrect use of the drug.  35%  of them had 
no  Albanian translation of leaflet.   
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Conclusions : Translation of leaflet in the official language is a necessity and an obligation 
of  all  importers. The absence of leaflets translation is in disagreement with the 
legislation of our country but also with the EU Directives on drugs 
commercialization and consumer’s health protection. The strengthening of regulatory 
agencies control in order to prevent the violation of the law is closely connected with the 
extensive interests of the citizens. 
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Introduction 
Leaflet of drugs are essential and very important in terms of a better use of the drug. 
Based on the very important information, which they contain, they are valid for doctors, 
pharmacists, as well as, for patients. Instructions given in these leaflets should be written in 
terms, which are understandable by all and, which include a summary of the characteristics of 
the drug. A leaflet should contain sufficiently detailed information about how to administer a 
drug, adverse effects, and drug interaction with other drugs or, when this drug is forbidden to 
be used. Under the PE and CE directives, translation in the official language of the country, in 
which those drugs circulate, is obligatory. According to the legislation of our country, 
importers of those drugs are obliged to translate in the Albanian language all the leaflets, 
which are found in any container of any pharmaceutical form of each medicament. There is a 
negligence of some importers to provide imported drugs with the leaflet translated into 
Albanian language. In this case, we have an open violation of law and, therefore leading to 
combating the problems that arise from their failure to comply. 
Background  Information 
The purpose of the study is exactly the authentication of the incidence of health 
consequences as a result of failing to translate the leaflet. That is evidence that failure to 
translate the leaflet has led to health consequences not only in medicine, but also to dietetic 
supplements. The study was based on the implementation of a combined approach, which 
includes two stages. 
• First, the study of the leaflet receipt. 
• Second, drafting of a questionnaire which was addressed to different people. 
The study addresses the importance of the translation of leaflet, which was found 
inside the drugs package. First, let’s explain what is needed to understand through the leaflet. 
Leaflet is a very important element, which provides explanations about active 
substances, about the drug, its dosage and, what is most important, about the side effects or 
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interactions with the other drugs, or its disuse in the case of certain diseases or in the certain 
age groups.    The obligation to provide drugs with leaflets is laid down in Directive 2001/83 / 
EC, in the Law No. 9323 of 25 November 2004 “On medicines and health service in Albania” 
and, in Law No. 9902 of 17 April 2008 “ On the protection of consumers”. Doctors and 
pharmacists receive information on how a drug should be used in the summary of product, 
while information for the patient can be included on the label. Under the aforementioned 
Directive and national legislation, the importing entities, before importing the drugs, should 
not only be subject to the obligation providing the drugs with the leaflets, but they should also 
translate them into the official language, which, in our case, is Albanian. 
We should address such challenges, which we encounter in our daily practices, and we 
as professionals should play the role of translator in the cases when the drugs do not have the 
leaflet translated into Albanian. 
The pharmaceutical market in Albania is sufficiently heterogeneous, therefore having 
a wide range of pharmaceutical companies from various countries of five continents and, as a 
result of this, the leaflets may be written in several languages. The open pharmacies and 
hospitals network includes a circulation of more than 600 active substances in various forms 
of pharmaceuticals. 
Why is translation of leaflets important? 
2.1a To eliminate misuse of the drug. 
2.1.b To eliminate drug use by persons who are of the age, for which it is clearly 
stated that they should not use it. 
2.1.c To prevent incompatibility between drugs. 
2.1.d To continue treatment for the period necessary to achieve the desired effect. 
2.1e To use a recommended dose for different ages and bodyweights. 
2.1.f To stop using it in the case of other diseases present in the body. 
2.1.g To maintain the drug in optimal condition. 
2.1.h To understand what are the adverse effects which may occur during the use of 
the drug. 
Who uses the information provided in the leaflet? 
2.2.a Doctors, when new drugs enter circulation after registration in the NCDC, or 
after receiving the permission of the Ministry of Health. 
2.2.b Nurses in order to prevent errors in their use. 
2.2.c Pharmacists in order to provide to the patients precise guidelines on the use of 
the drug. 
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2.2.d Patients and their families to be as clear as possible about the use and 
preservation of the drug especially in the case of drugs that are in the list of 
OTC drugs. 
The relationship between the translation and the good use of the drug. 
2.3.a Translation of chemical composition of active substances and auxiliary 
substances informs the patients about the possibility of the presence of allergies 
in one or more ingredients. Incompatibility with other drugs, which the patient 
uses as active substances or as excipients. 
2.3.b Translation of the side effects as listed by level of frequency will provide the 
patients and/or medical staff with the opportunity to share a frequent effect 
with an unexpected side effect. 
International Standards of leaflets translation. 
Patients should be fully aware of their therapeutic treatment, therefore the information 
available to them must fully comply with the summary of product characteristics. The 
marketing authorization holder bears the responsibility for the best translation of the leaflets. 
Under the legislation in force, the translated text should not be short and simple, therefore it 
should be clear, readable, easy to understand for any age and gender.  
Methods 
The following  drugs  constitute  the  scope  of  this  study.  For  the  convenience  of 
the  study  and  to  reach  more  precise  conclusions, these  substances  were  grouped 
according  to  the  active  pharmaceutical  form  and  manufacturing  firm.  National  products 
were  excluded  from  this  study  for  the  sole  reason  that  their  Leaflet  have  been  in 
Albanian.  The  exact   number  of  leaflets,  which  represented  an  active  substance  of  a 
certain  manufacturing  company,  was  400,  including  also  the  dietary  and  nutritional 
supplements.  According  to  a  simple  counting  we  carried  out  regarding  these  leaflets,  it 
resulted  that  35%  (140)  had  not  been  translated  into  Albanian,  35%  (25)  of  which 
belonged  to  nutritional  supplements. 
 
 
Figure1. Number of leaflets included in the survey. 
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Leaflets  included  in  the  study   were  obtained  in  different  languages  as  follows: 
35%  (140)  in  English,  35%  (140)  in  Italian,  10%  (40)  in  German,  10%  (40)  in  Slavic 
languages,  3%  (12)  in  Turkish,  7%  (28)  in  French 
 
Figure 2. Foreign languages, in which the surveyed leaflets were written. 
In Albania, continuous efforts have been made to increase the readability of leaflets 
based on BE Directives. The task  of the study was to test the readability of the leaflets. 
Testing addressed all respondents without any prior selection and included the readability of 
five leaflets in English, Italian, German, Turkish, French. The selected leaflets belonged to 
drugs, which are widely used by all age groups. 
Respondents had to explain some of the key information transmitted to the patients 
through the leaflets. The following graphic presentation provides a schematic description of 
the processing of results, which came out of the questionnaire.  
People, sick or not, and people of different ages were asked. They were surveyed in 
ambulatory centers, in hospitals, pharmacies, on streets or via phone. 
The respondents were of different ages ranging from the age 18. There was not any 
preliminary careful selection to see if they were regularly users of drugs, instead it was all 
random. 
Those patients and many other citizens were subjects of our survey. The drafted 
questionnaire consisted of certain questions, which were related exactly to the problem that 
was addressed. 
European Scientific Journal    December edition vol.8, No.30    ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
44 
 
 
Figure 3. Survey results on readability of leaflets. 
Test results of the test are satisfactory when 90% of the respondents manage to 
understand the information, which is provided in the leaflet and do not have difficulties to act 
accurately under the guidelines that are provided there. The questionnaire included several 
key safety messages: 
3.1.a why patients need to take the product; 
3.1.b maximum dose or duration of treatment; 
3.1.c significant drug interactions 
3.1.d circumstances, in which the drug should be stopped 
3.1.f when the drug is strictly forbidden to use. 
Many  prestigious  companies,  such  as  Novartis,  Glaxo,  Bayer  and  others  had  not 
Leaflet  of  their  own  active  substances  in  the  Albanian  language.  Substances  of  these 
companies  had  an  active  diverse  form  and  doses  are  referred  to  antibiotics, 
antihypertensive,  antidiabetic,  dermatological,  gynecological  etc.   
The  difficulty  of  understanding  the  leaflet  in  many  cases  has  led  to  health 
concerns  in  the  case  of  patients  who  have  used  these  drugs.  
Summary  and  Conclusion: 
 Following the statistical processing of the results, we found that out of 1500 
respondents 60% (900) of them did not understand explanations of drugs, because the 
explanations were in foreign languages, 25% (375) were obliged to seek assistance from 
family members or friends, 10%(150) had to translate the leaflet by themselves , 5% (75) 
were not interested because they trusted a doctor or a pharmacist, 44% (660) had been, at 
least, once concerned about the incorrect use of drug. 
 The survey results showed that patients want more information than they currently 
receive and use through leaflets, serving as an information source for physicians and 
pharmacists. 
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 Accurate information helps the participation of patients and the medical staff when the 
latter recommend the drugs. In the case of OTC medications, complete information should be 
taken to avoid in advance treatment errors, which may be the result of insufficient information 
that may be received when a non-professional translation attempt is made by the specialist of 
the language in question.  
 The label accompanying the drug should also include guidance for the patient in the 
form of a leaflet (PIL), which provides information complying with the Summary of Product 
Characteristics (SPC). This information would be very useful mainly for chronic patients who 
use medications for extended periods of time. In order to understand the leaflet more easily, 
the medical staff and patients are required first to take into account a number of criteria, 
which are listed as follows: 
4.a Do not use medical jargon, which is difficult to be understood by the large public. 
4.b Translation should be in the official literary language. 
4.c Use short and clear sentences. 
4.d  Do not use stereotyped phrases to explain the side effects of the drug. 
4.e Side effects should be grouped and ranked according to the degree of threat and the 
frequency of incidence to enable the patient to take measures if they would occur. 
There have been improvements but there is still much to do. A large number leaflets, 
which are inside the packaging of drugs and, which are in the market, are not translated 
correctly or, the information that they convey to patients is inadequate. In order to achieve 
perfection in translating these leaflets, a larger investment is required to be made by the 
importing companies. Improvement of translation should be done without altering the content  
and based on the relevant guidelines, therefore working more with how these leaflets should 
be formatted, the type of writing and the size of the font to be used, the placement of 
information in order to facilitate in this way reading and understanding.  
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